About Luc7-like protein 3
Luc7-like protein 3 (LUC7L3) is a protein
from Homo sapiens identified by UniProt accession
O95232, 432 residues long.
MolForge cross-references it against 0 known binders and
53 disease associations.
Target properties
| Protein name | Luc7-like protein 3 |
| UniProt accession | O95232 |
| Gene | LUC7L3 |
| Organism | Homo sapiens |
| Length | 432 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (53)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.48
- urate measurement · score 0.15
- bone density · score 0.15
- hepatocellular carcinoma · score 0.05
- primary familial polycythemia due to EPO receptor mutation · score 0.05
- heel bone mineral density · score 0.05
- hemolytic anemia due to diphosphoglycerate mutase deficiency · score 0.04
- dehydrated hereditary stomatocytosis · score 0.04
- Pyruvate kinase hyperactivity · score 0.04
- hemolytic anemia due to erythrocyte adenosine deaminase overproduction · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95232-F1 | alphafold | PREDICTED | 70.18 | — |
Amino-acid sequence (432 residues)
MISAAQLLDE LMGRDRNLAP DEKRSNVRWD HESVCKYYLC GFCPAELFTN TRSDLGPCEK IHDENLRKQY EKSSRFMKVG YERDFLRYLQ SLLAEVERRI RRGHARLALS QNQQSSGAAG PTGKNEEKIQ VLTDKIDVLL QQIEELGSEG KVEEAQGMMK LVEQLKEERE LLRSTTSTIE SFAAQEKQME VCEVCGAFLI VGDAQSRVDD HLMGKQHMGY AKIKATVEEL KEKLRKRTEE PDRDERLKKE KQEREEREKE REREREERER KRRREEEERE KERARDRERR KRSRSRSRHS SRTSDRRCSR SRDHKRSRSR ERRRSRSRDR RRSRSHDRSE RKHRSRSRDR RRSKSRDRKS YKHRSKSRDR EQDRKSKEKE KRGSDDKKSS VKSGSREKQS EDTNTESKES DTKNEVNGTS EDIKSEGDTQ SN
Explore Luc7-like protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets